Cleared Traditional

K924674 - DIRECT LDL CHOLES IMMUNOSEPARATION REAGENT

K924674 is an FDA 510(k) clearance for DIRECT LDL CHOLES IMMUNOSEPARATION REAGENT, manufactured by Genzyme Corp.. The device is a Class 1 Chemistry device with product code MRR cleared through the Traditional 510(k) pathway after a 112-day FDA review.

K924674 · Genzyme Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1993
Decision
112d
Days
Class 1
Risk

K924674 is an FDA 510(k) clearance for the DIRECT LDL CHOLES IMMUNOSEPARATION REAGENT. Classified as System, Test, Low Density, Lipoprotein (product code MRR), Class I - General Controls.

Submitted by Genzyme Corp. (Cambridge, US). The FDA issued a Cleared decision on January 6, 1993 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1475 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Genzyme Corp. devices

FDA 510(k) Submission Details - K924674

510(k) Number K924674 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1992
Decision Date January 06, 1993
Days to Decision 112 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 88d · This submission: 112d
Pathway characteristics
Predicate-based equivalence.

MRR Device Classification - Class 1, General Controls

Product Code MRR System, Test, Low Density, Lipoprotein
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - MRR System, Test, Low Density, Lipoprotein

All 27
Devices cleared under the same product code (MRR) and FDA review panel - the closest regulatory comparables to K924674.
RDI LIPIDIRECT MAGNETIC LDL REAGENT
K964064 · Reference Diagnostics, Inc. · Nov 1996
EKTACHEM DT LDL CHOLESTEROL KIT
K955904 · Johnson & Johnson Clinical Diagnostics, Inc. · May 1996
DIRECT LDL CHOLESTEROL IMMUNOSEPARATION REAGENT KIT
K943150 · Genzyme Corp. · Mar 1995
LIPIDIRECT LOW DENSITY LIPOPROTEIN CHOLESTEROL TES
K893740 · Reference Diagnostics, Inc. · Mar 1990